Anuh Pharma Tarapur facilities clear USFDA inspection with zero observations

Business Updates View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.4%Reaction day

₹79.95

prior close

₹84.14

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.6%+0.8% vs market

Pharmaceuticals peers, median of 159sector+1.8%+1.7% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Microcap 250 and 1.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.0

15m

-1.4

30m

-1.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.4+2.6+0.8+1.8+1.7

Next day

+4.6+3.6+1.0+2.4+2.3

+3.2+3.1+0.1+2.0+1.2

+2.0+2.6-0.6+1.2+0.8

+1.2+1.1+0.1+0.7+0.5

+1.2+0.3+0.9+0.0+1.2

-2.5+1.6-4.1+0.8-3.3

15d

-3.1-3.9+0.9-4.4+1.3

-2.4-8.1+5.7-5.3+2.8

-1.8-3.1+1.3-3.0+1.1

+3.8+9.2-5.3+5.0-1.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma's three manufacturing units at MIDC Tarapur (Boisar) in Palghar, Maharashtra were inspected by the USFDA. The inspection closed with no Form 483 observations, confirming the facilities meet global regulatory and quality standards. A Form 483 is issued when inspectors find conditions that may violate FDA rules, so a clean outcome is a positive compliance signal for the company's US market presence.

Likely market impact

Boosts confidence in manufacturing quality, supports uninterrupted US shipments and reduces regulatory risk for the stock.